Loading clinical trials...
Loading clinical trials...
Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study
Conditions
Interventions
AC regimen
cyclophosphamide
+2 more
Locations
527
United States
Regional Medical Center
Anniston, Alabama, United States
UAB Comprehensive Cancer Center
Birmingham, Alabama, United States
Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
Start Date
May 1, 2002
Primary Completion Date
April 1, 2012
Completion Date
June 1, 2014
Last Updated
May 18, 2017
NCT04541381
NCT05468034
NCT03137095
NCT04852887
NCT06393374
NCT07040891
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions